MELK Recombinant Antibody, FITC Conjugated
Product Specifications
Background
Serine/threonine-protein kinase involved in various processes such as cell cycle regulation, self-renewal of stem cells, apoptosis and splicing regulation. Has a broad substrate specificity; phosphorylates BCL2L14, CDC25B, MAP3K5/ASK1 and ZNF622. Acts as an activator of apoptosis by phosphorylating and activating MAP3K5/ASK1. Acts as a regulator of cell cycle, notably by mediating phosphorylation of CDC25B, promoting localization of CDC25B to the centrosome and the spindle poles during mitosis.
Synonyms
HMELK; hPK38; MELK; mKIAA0175; MPK38.
Gene ID
9833
Swiss Prot
Q14680
Cellular Locus
Cytoplasm
Host
Rabbit
Cross Reactivity
Human
Target
MELK
Clonality
Recombinant
Conjugation
FITC
Source
KLH conjugated synthetic peptide derived from human MELK
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
494nm/518nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
9833
Isotype
IgG
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
A2295-01W8-ML490 100 µL
Angiotensin Converting Enzyme 2, ACE 2 (MaxLight 490) discontinued
Ask
View Details 
RG-E082544-01 10 mg
(4Z,7Z,10Z,13Z,16Z,19Z) -Ethyl Docosa-4,7,10,13,16,19-Hexaenoate
Ask
View Details 
RG-E082544-02 25 mg
(4Z,7Z,10Z,13Z,16Z,19Z) -Ethyl Docosa-4,7,10,13,16,19-Hexaenoate
Ask
View Details